No Data
No Data
US Physical Therapy Positioned For Success Despite Medicare Challenges, Analyst Optimistic On Unique Growth Strategy
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
BofA Securities Upgrades US Physical Therapy(USPH.US) to Buy Rating, Announces Target Price $115
US Physical Therapy Raised to Buy From Neutral by B of A Securities
Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), AnaptysBio (ANAB) and US Physical Therapy (USPH)
JMP Securities Initiates US Physical Therapy(USPH.US) With Buy Rating, Announces Target Price $113
No Data